DGAP-Adhoc: MEDIQON Group AG: Placement of the capital increase with subscription rights successfully completed

DGAP-Ad-hoc: MEDIQON Group AG / Key word(s): Corporate Action
MEDIQON Group AG: Placement of the capital increase with subscription rights successfully completed

07-Apr-2022 / 19:33 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

MEDIQON Group AG has successfully placed all new shares from the capital increase with subscription rights resolved on March 15, 2022.

The capital increase is subject to the entry in the commercial register. The share capital of the company will increase from EUR 10,999,513.00 to EUR 14,999,333.00 by issuing to 3,999,820 new shares against cash contribution. The subscription price amounts to EUR 10.40 per share. The gross proceeds from the capital increase amount to EUR 41,598,128.00

All new shares will be included in the existing listing on the Basic Board (Open Market) of the Frankfurt Stock Exchange.

07-Apr-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	MEDIQON Group AG
	Herzog-Adolph-Strasse 2
	61462 Königstein im Taunus
	Germany
Phone:	+49 (0) 6174-9687040
Fax:	+49 (0) 6174-9687043
E-mail:	ir@mediqon-group.de
Internet:	www.mediqon-group.de
ISIN:	DE0006618309, DE000A254TL0
WKN:	661830, A254TL
Listed:	Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart
EQS News ID:	1323255


End of Announcement	DGAP News Service

1323255 07-Apr-2022 CET/CEST